Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Diagnostics & Research

Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA, tests for sexually transmitted diseases, vitamin D testing, microbiology cultures and procedures, and alcohol and other substance abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations. In addition, the company offers digital pathology solutions, a pathology platforms that support the digitization, centralized review, and sharing of pathology slides; provider and payer digital platforms, an online applications for providers, MCOs, and ACOs; online and mobile applications that enable patients to check offerings, schedule PSC visits, check-in upon PSC arrival, complete documentation, access tests and test results, and manage their accounts; and Generative AI-enabled Test Selection, a generative AI-enabled tool. It serves clients, third party, medicare/medicaid, patients, pharmaceutical, biotechnology, medical device, diagnostic companies, and CROs. The company was founded in 1995 and is headquartered in Burlington, North Carolina.

Revenue projections:

Revenue projections for LH
Revenue projections for LH

Labcorp Holdings Inc.'s revenue projections indicate a decrease from the prior year, which may make investors hesitant. A revenue decline could harm the company's bottom line, prompting investors to be more careful, as lower earnings often signal potential issues with profitability and future performance.

Financial Ratios:

currentRatio 1.424000
forwardPE 13.287819
debtToEquity 75.561000
earningsGrowth 0.157000
revenueGrowth 0.056000
grossMargins 0.287600
operatingMargins 0.105500
trailingEps 11.300000
forwardEps 19.325970

LH's current ratio of 1.424 indicates strong liquidity, meaning the company can comfortably meet its short-term debt obligations. This financial position reflects LH's ability to use its cash reserves and current assets to cover liabilities without facing any cash flow issues.
LH's Forward PE being in a reasonable range suggests the stock is fairly priced based on its earnings. The stock isn't overpriced, leaving room for growth, making it an attractive investment for those seeking opportunities for future value appreciation.
Labcorp Holdings Inc.'s forward EPS surpassing its trailing EPS signals that the company is anticipated to be more profitable this year than last. This growth expectation highlights Labcorp Holdings Inc.'s potential for increased earnings and a stronger financial performance in the upcoming year.

Price projections:

Price projections for LH
Price projections for LH

Over time, price projections for LH have risen steadily, pointing to growing optimism among analysts about the company's future. This upward trend suggests a positive outlook for LH's continued growth.

Insider Transactions:

Insider Transactions for LH
Insider Transactions for LH


LH experienced 26 selling transactions, with market price of 265.1538948645958.There were no sell transactions during the period under consideration.The trend of more buys compared to sells around Labcorp Holdings Inc.'s current price levels may signal investor optimism. This behavior suggests that the market is expecting a favorable outcome for the stock, leading to increased buying activity.

Recommendation changes over time:

Recommendations trend for LH
Recommendations trend for LH


A recent buy bias from analysts toward LH may inspire confidence in investors, who could view the stock as a promising investment. This positive sentiment suggests that LH might be an appealing option for those looking to grow their wealth through stock market investments.